No insider purchase over the last 90 days. The latest, by 김현수, was filed 10 Jul 2026.
Pharmicell Co., Ltd.: what insiders have been doing
This page follows insider dealings at Pharmicell Co., Ltd. as filed with DART (FSS), a company from the Health Care sector. Over the twelve months to 2 November 2026, 13 filings were filed, from 9 insiders.
On the market, 7 insiders bought (10 purchases) while 1 insider sold (1 sale). The totals do not cover 11 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 3 board members, 3 senior executives and 1 major shareholder.
The clock since the last published purchase (10 July 2026) now reads 122 days. Filings reach the DART (FSS) feed a median of 4 days after the trade. This delay matters because a trade only becomes useful information once it is public.
With 13 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 34 purchases and 1 sale.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySale+1 other insider
Since the insiders bought
- -17.6%Entry ₩11,410 · Close 30 Oct 2026 ₩9,400
- -29.9%Entry ₩13,400 · Close 30 Oct 2026 ₩9,400
- -29.9%Entry ₩13,400 · Close 30 Oct 2026 ₩9,400
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- 668 sharesKRXDART:20260710000449Canonical exit: 8 Oct 2026 (T+90)
- 668 sharesShareKRXDART:20260619000463Canonical exit: 17 Sept 2026 (T+90)
- 668 sharesShareKRXDART:20260619000454Canonical exit: 17 Sept 2026 (T+90)
- 668 sharesShareKRXDART:20260619000435Canonical exit: 17 Sept 2026 (T+90)
- 668 sharesShareKRXDART:20260619000443Canonical exit: 17 Sept 2026 (T+90)
- 668 sharesShareKRXDART:20260619000470Canonical exit: 17 Sept 2026 (T+90)
- 668 sharesShareKRXDART:20260619000424Canonical exit: 17 Sept 2026 (T+90)
- 50,000 sharesKRXDART:20260415000438
- ●Executives0DART
- 14,000 sharesShareKRXDART:20260128000014Canonical exit: 28 Apr 2026 (T+90)
- 14,000 sharesKRXDART:20260127000012Canonical exit: 26 Apr 2026 (T+90)
- 978 sharesShareKRXDART:20260119000252Canonical exit: 19 Apr 2026 (T+90)
- ●Executives0DART
- 10,300 sharesShareKRXDART:20250430000963Canonical exit: 29 Jul 2025 (T+90)
- 10,300 sharesKRXDART:20250429000040Canonical exit: 27 Jul 2025 (T+90)
- 343 sharesKRXDART:20240823000255Canonical exit: 20 Nov 2024 (T+90)
- ShareKRXDART:20240726000353Canonical exit: 22 Oct 2024 (T+90)
- ShareKRXDART:20240726000347Canonical exit: 22 Oct 2024 (T+90)
- ShareKRXDART:20240726000334Canonical exit: 22 Oct 2024 (T+90)
- ShareKRXDART:20240726000359Canonical exit: 22 Oct 2024 (T+90)
- ShareKRXDART:20240726000372Canonical exit: 22 Oct 2024 (T+90)
- 80 sharesShareKRXDART:20240108000339Canonical exit: 31 Mar 2024 (T+90)
- 343 sharesKRXDART:20231005000132Canonical exit: 26 Oct 2023 (T+90)
- 343 sharesKRXDART:20230503000234Canonical exit: 1 Aug 2023 (T+90)
25 of 50 declarations
About Pharmicell Co., Ltd.
파미셀 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
